Based on the subjects’ characteristics, the study by Roessler et al. [29] evaluated IgE, macrophage-derived chemokine (MDC) and IL-16 in patients with AD and compared these results with healthy subjects. This evidence concerns the gene CCL22 and Alzheimer disease.